Scopolamine augments c-fos and zif/268 messenger RNA expression induced by the full D1 dopamine receptor agonist SKF-82958 in the intact rat striatum

Neuroscience

Volumn 72, Issue 3, 1996, Pages 601-616

  Wang, J Q ^a   McGinty, J F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

acetylcholine; immediate early gene; muscarinic receptors; nucleus accumbens; SKF 38393; SKF 82958

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; MESSENGER RNA; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE; SKF 23390; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029919621     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00597-8     Document Type: Article

References (76)

1. Anderson J. J., Chase T. N. and Engber T. M. (1993) Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats. Brain Res. 623, 189-194.
2. Anderson P. H. and Jansen J. (1990) Dopamine receptor agonists: selectivity and dopamine receptor efficacy. Eur. J. Pharmac. 188, 335-347.
3. 3 subtypes. Brain Res. 649, 95-110.
4. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmac. Toxic. 62, 121-130.
5. 2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum. Neuroscience 53, 417-424.
6. Bergson C., Mrzljak L., Lidow M. S., Goldman-Rakic P. S. and Levenson R. (1995) Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells. Proc. natn. Acad. Sci. U.S.A. 92, 3468-3472.
7. Bernard V., Dumartin B., Lamy E. and Bloch B. (1993) Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat. Eur. J. Neurosci. 5, 1218-1225.
8. Bernard V., Normand E. and Bloch B. (1992) Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12, 3591-3600.
9. Bhat R. V. and Baraban J. M. (1992) High basal expression of zif/268 in cortex is dependent on intact noradrenergic system. Eur. J. Pharmac. 227, 447-448.
10. Bolam J. P., Wainer B. H. and Smith A. D. (1984) Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi impregnation and electron microscopy. Neuroscience 12, 711-718.
11. 125I]-iodosulpride. Synapse 19, 1-13.
12. 2 receptor mRNA. Brain Res. 564, 203-219.
13. Bymaster F. P., Heath I., Hendrix J. C. and Shannon H. E. (1993) Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J. Pharmac. exp. Ther. 267, 16-24.
14. Chang H. T. (1988) Dopamine-acetylcholine interaction in the rat striatum: a dual-labeling immunocytochemical study. Brain Res. Bull. 21, 295-304.
15. Chio C. L., Lajiness M. E. and Huff R. M. (1993) Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Molec. Pharmac. 45, 51-60.
16. Chou H., Ogawa N., Asanuma M., Hirata H. and Mori A. (1992) Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain. J. neural Transm. 90, 171-181.
17. 1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58, 1420-1426.
18. 2 dopamine receptors and the regulation of striatal acetylcholine release in vivo. Prog. Brain Res. 98, 201-207.
19. Consolo S., Wu C. F., Fiorentini F., Ladinsky H. and Vezzani A. (1987) Determination of endogenous acetylcholine release in freely moving rats by transstriatal dialysis coupled to a radioenzymatic assay: effect of drugs. J. Neurochem. 48, 1459-1465.
20. 1 receptor stimulation increases striatal acetylcholine release in the rat. Eur. J. Pharmac. 186, 335-338.
21. Di Chiara G., Carboni E., Morelli M., Cozzolino A., Tanda G. L., Pinna A., Russi G. and Consolo S. (1993) Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and Fos immunohistochemistry. Neuroscience 55, 451-456.
22. Di Chiara G., Morelli M. and Consolo S. (1994) Modulatory functions of neurotransmitters in the striatum: ACH/dopamine/NMDA interactions. Trends Neurosci. 17, 228-234.
23. Dilts R. P. Jr, Helton T. E. and McGinty J. F. (1993) Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields. Synapse 13, 251-263.
24. Dimova R., Vullet J., Nieoullon A. and Goff L. K. L. (1993) Ultrastructural features of the choline acetyltransferase-containing neurons and relationship with nigral dopaminergic and cortical afferent pathways in the rat striatum. Neuroscience 53, 1059-1071.
25. Dokas L. A. and Ting S. M. (1993) A comparison of the regulatory properties of striatal and cortical adenylate cyclase. Neurobiol. Aging 14, 65-72.
26. Dragunow M., Robertson G. S., Faull R. L. M., Robertson H. A. and Jansen K. (1990) D2 dopamine receptor antagonists induce Fos and related protein(s) in rat striatal neurons. Neuroscience 37, 287-294.
27. Gerfen C. R. (1991) Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556, 165-170.
28. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432.
29. Graybiel A. M., Moratalla R. and Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix and limbic subdivisions of the striatum. Proc. natn. Acad. Sci. U.S.A. 87, 6912-6916.
30. Guennoun R. and Bloch B. (1992) Ontogeny of D1 and DARPP-32 gene expression in the rat striatum: an in situ hybridization study. Molec. Brain Res. 12, 131-139.
31. Hulme E. C., Birdsall N. J. M. and Buckley N. J. (1990) Muscarinic receptor subtypes. A. Rev. Pharmac. Toxic. 30, 633-673.
32. Huntley G. W., Morrison J. H., Prikhozhan A. and Sealfon S. C. (1992) Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum. Molec. Brain Res. 15, 181-188.
33. Izzo P. N. and Bolam J. P. (1988) Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat. J. comp. Neurol. 269, 219-234.
34. 1-dopamine agonist SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. J. Pharmac. exp. Ther. 262, 855-865.
35. 1 receptor agonist with antiparkinsonian activity in marmosets. Eur. J. Pharmac. 229, 203-209.
36. 2 synergism and receptor supersensitivity. Proc. natn. Acad. Sci. U.S.A. 90, 7451-7455.
37. Lapper S. R. and Bolam J. P. (1992) Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of rat. Neuroscience 51, 533-545.
38. Laurier L. G., O'Dowd B. F. and George S. R. (1994) Heterogeneous tissue-specific transcription of dopamine receptor subtype messenger RNA in rat brain. Molec. Brain Res. 25, 344-350.
39. Le Moine C. and Bloch B. (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. comp. Neurol. 355, 418-426.
40. Le Moine C., Normand E. and Bloch B. (1991) Phenotypical characterization of rat striatal neurons expressing the D1 dopamine receptor gene. Proc. natn. Acad. Sci. U.S.A. 88, 4205-4209.
41. 3 receptor mRNA and binding sites in human brain. Molec. Brain Res. 18, 187-192.
42. 2 receptor binding in the rat brain and pituitary: an in situ hybridization receptor autoradiographic analysis. J. Neurosci. 10, 2587-2600.
43. 5 dopamine receptor mRNA in rat brain. Neurosci. Lett. 145, 209-212.
44. Meredith G. E. and Wouterlood F. G. (1990) Hippocampal and midline thalamic fibres and terminals in relation to the choline acetyltransferase-immunoreactive neurons in nucleus accumbens of the rat: a light and electron microscopic study. J. comp. Neurol. 296, 204-221.
45. 1 receptor family agonists, SKF38393, SKF77434, and SKF82958, differentially affect locomotor activities in rats. Pharmac. Biochem. Behav. 46, 269-274.
46. Miller J. C. (1990) Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J. Neurochem. 54, 1453-1455.
47. Moratalla R., Robertson H. A. and Graybiel A. M. (1992) Dynamic regulation of NGFI-A (zif/268, egrl) gene expression in the striatum. J. Neurosci. 12, 2609-2622.
48. 2 mediated responses. Neuroscience 53, 673-678.
49. Morelli M., Pinna A., Fenu S., Carta A., Cozzolino A. and Di Chiara G. (1994) Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats. Synapse 18, 288-293.
50. 2 interaction. Eur. J. Pharmac. 160, 377-384.
51. Nestler E. J. (1994) Molecular neurobiology of drug addiction. Neuropsychopharmacology 11, 77-87.
52. 1 dopamine receptor. Neuropharmacology 28, 401-405.
53. Parent A. (1990) Extrinsic connections of the basal ganglia. Trends Neurosci. 13, 254-258.
54. Paul M. L., Graybiel A. M., David J. C. and Robertson H. A. (1992) D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12, 3729-3741.
55. Pfeiffer F. R., Wilson J. W., Weinstock J., Kuo G. Y., Chambers P. A., Holden K. G., Hahn R. A., Wardell J. R. Jr, Tobia A. J., Setler P. E. and Sarau H. M. (1982) Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. J. med. Chem. 25, 352-358.
56. Phelps P. E., Houser C. R. and Vaughn J. E. (1985) Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: a correlated light and electron microscopic study of cholinergic neurons and synapses. J. comp. Neurol. 238, 286-307.
57. 2 receptors. Molec. Neurobiol. 6, 425-450.
58. 2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience 64, 1019-1034.
59. 1 dopamine receptor-activated c-fos. Brain Res. 523, 288-290.
60. Robertson H. A., Peterson M. R. and Murphy K. (1989) D1 dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res. 503, 346-349.
61. Robertson H. A., Paul M. L., Moratalla R. and Graybiel A. M. (1991) Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can. J. neurol. Sci. 18, 380-383.
62. Ruskin D. N. and Marshall J. F. (1994) Amphetamine- and cocaine-induced Fos in the rat striatum depends on D2 dopamine receptor activation. Synapse 18, 233-240.
63. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res. 582, 349-352.
64. Setler P. E., Sarau H. M., Zirkle C. L. and Saunders H. L. (1978) The central effects of a novel dopamine agonist. Eur. J. Pharmac. 50, 419-430.
65. Smith A. J. W. and McGinty J. F. (1994) Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Molec. Brain Res. 21, 359-362.
66. Wang J. Q., Daunais J. B. and McGinty J. F. (1994) NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18, 343-353.
67. Wang J. Q., Daunais J. B. and McGinty J. F. (1994) Role of kainate/AMPA receptors in induction of striatal zif/268 and preprodynorphin mRNA by a single injection of amphetamine. Molec. Brain Res. 27, 118-126.
68. 2 dopamine receptor antagonists on acute amphetamine-or methamphetamine-induced upregulation of zif/268 mRNA expression in rat forebrain. J. Neurochem. 65, 2706-2715.
69. Wang J. Q. and McGinty J. F. (1996) Muscarinic receptors regulate striatal neuropeptide gene expession in normal and amphetamine-treated rats. Neuroscience (in press).
70. Wang J. Q. and McGinty J. F. (1995) Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J. Pharmac. exp. Ther. 273, 909-917.
71. Wang J. Q., Smith A. J. W. and McGinty J. F. (1995) A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin mRNA expression in rat forebrain. Neuroscience 68, 83-95.
72. Weiner D. M., Levey A. and Brann M. R. (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. natn. Acad. Sci. U.S.A. 87, 7050-7054.
73. 2 dopamine receptors on Fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35, 85-91.
74. 1 receptors. Proc. natn. Acad. Sci. U.S.A. 88, 1291-1295.
75. Young W. S., Mezey E. and Siegel R. E. (1986) Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci. Lett. 70, 198-203.
76. 1 dopamine receptors in striatum and not the frontal cortex. Brain Res. 627, 186-192.